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Innate immune signaling associated with Toll-like receptors (TLRs) is a key pathway involved in the
progression of liver ﬁbrosis. In this study, we reported that TLR2 is required for hepatic ﬁbrogenesis
induced by carbon tetrachloride (CCl4). After CCl4 treatment, TLR2/mice had reduced liver enzyme
levels, diminished collagen deposition, decreased inﬂammatory inﬁltration and impaired activation
of hepatic stellate cells (HSCs) than wild type (WT) mice. Furthermore, after CCl4 treatment, TLR2
/
mice demonstrated downregulated expression of proﬁbrotic and proinﬂammatory genes and
impaired mitogen-activated protein kinases (MAPK) and nuclear factor kappa B (NF-jB) activation
thanWTmice. Collectively, our data indicate that TLR2 deﬁciency protects against CCl4-induced liver
ﬁbrosis.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction are the major source of extracellular matrix components and canLiver ﬁbrosis, as the ﬁnal common endstage of most chronic
liver diseases [1], is triggered by chronic liver injury caused by
various etiologies including viral infection, cholestasis, metabolic
diseases and alcohol abuse [2,3]. It is a reversible wound-healing
response characterized by the accumulation of extracellular matrix
proteins (ECM) including collagen [4]. Hepatic stellate cells (HSCs)transdifferentiate into hepatic myoﬁbroblasts closely involved in
proliferation and collagen synthesis. Moreover, the ‘‘activated’’
HSCs have been shown to contribute to expression of a-smooth
muscle actin (a-SMA) and proﬁbrotic cytokines such as transform-
ing growth factor b1 (TGF-b1) and platelet-derived growth factor
(PDGF) [5]. Additionally, the inﬂammatory cytokines (e.g., IL-6)
produced by Kupffer cells, the liver resident macrophage, aggra-
vate liver ﬁbrosis [6]. The correlation between inﬂammation and
ﬁbrosis progression has been increasingly clariﬁed recently [7].
However, little is known about the direct biological effect of
inﬂammatory mediators on liver ﬁbrogenesis. Since the demon-
stration that even advanced liver ﬁbrosis is reversible [8], there
is a dire need to uncover the molecular mechanisms underlying
the association between liver inﬂammation and ﬁbrogenesis.
Toll like receptors (TLRs), a class of pattern recognition recep-
tors that can recognize pathogen-associated molecular patterns
(PAMPs) and damage-associated molecular patterns (DAMPs), play
a speciﬁc role in the regulation of inﬂammation [9,10]. Upon
activated by agonists, TLRs initiate a signaling cascade resulting
in the stimulation of innate and adaptive immune responses [11].
TLR2 acts as a receptor for cell-wall components of gram-positive
2096 L. Ji et al. / FEBS Letters 588 (2014) 2095–2100bacteria (peptidoglycan, PGN and lipoteichoic acid, LTA), which
play a signiﬁcant role in the pathogenesis of severe inﬂammatory
responses [12,13]. Accumulating evidence has indicated that
TLR2 signal can not only activate the ASK1/p38 MAPK/NF-KB sig-
naling pathway, but can also stimulate the ERK/JNK and PI3K/Akt
pathways in a MyD88-independent manner [14]. On the other
hand, growing number of researches have proved that the gram-
positive bacteria products can initiate and perpetuate HSCs activa-
tion during liver inﬂammation and ﬁbrosis by upregulating the
TLRs level [15,16]. An important ﬁnding from Seki et al. was that
TLR4, but not TLR2, are required for hepatic ﬁbrogenesis [7].
However, a contradictory conclusion was drawn by Miura et al.
[17] who reported that TLR2 promoted liver inﬂammation and
ﬁbrogenesis in non-alcoholic steatohepatitis (NASH) induced by a
methionine- and choline-deﬁcient (MCD) diet. Therefore, the role
of TLR2 concerning liver ﬁbrosis progression needs additional
evidence.
In this study, we investigated the effect of TLR2 deﬁciency on
hepatic ﬁbrosis induced by carbon tetrachloride (CCl4). Our
ﬁndings showed that liver ﬁbrosis was ameliorated in TLR2/
mice as compared with wild type (WT) littermates in this model.Table 1
Primer sequences used for real-time PCR.
Gene Forward Primer (50–30) Reverse Primer (50–30)
Col1a1 GAGAGGTGAACAAGGTCCCG AAACCTCTCTCGCCTCTTGC
a-SMA AAACAGGAATACGACGAAG CAGGAATGATTTGGAAAGGA
TNF-a AGCCGATGGGTTGTACCTTG ATAGCAAATCGGCTGACGGT
TGF-b CTCCCGTGGCTTCTAGTGC GCCTTAGTTTGGACAGGATCTG
MCP-1 ATGCAGTTAACGCCCCACTC CCCATTCCTTCTTGGGGTCA
TIMP1 CCAGAACCGCAGTGAAGAGT GTACGCCAGGGAACCAAGAA
Ccl4 CCCAGCTCTGTGCAAACCTA CCATTGGTGCTGAGAACCCT
PDGFR CGAAAACTGTCACCCACACC GTGACCTCCTGCGAATCTCC
IL-6 GAGTGGCTAAGGACCAAGACC AACGCACTAGGTTTGCCGA
TLR4 GGTGTGAAATTGAGACAATTGA GTTTCCTGTCAGTACCAAGGTTG
CXCL-1 GCTGGGATTCACCTCAAGAA TGGGGACACCTTTTAGCATC
CXCL-2 CGCTGTCAATGCCTGAAGAC ACACTCAAGCTCTGGATGTTCTT
GAPDH TGCCGCCTGGAGAAACCT TGAAGTCGCAGGAGACAACC2. Materials and methods
2.1. Animals and mouse model of liver ﬁbrosis
TLR2/ mice on a C57BL/6J background were purchased from
Jackson Laboratories (Bar Harbor, ME). Wild-type (WT) C57BL/6J
mice were from Shanghai Laboratory Animal Center (Chinese
Academy of Sciences, Shanghai, China). Male 8–10 weeks old
(25–30 g)WT and TLR2/mice were housed in a speciﬁc pathogen
free facility with a 12-h light/dark cycle, and fed ad libitum with
regular chow food and water throughout the study period. Chronic
CCl4-dependent liver ﬁbrosis was induced by intra-peritoneal CCl4
(diluted to 20% with corn oil) administrated as a dose of 6 ll/g
body weight 3 times a week for 6 weeks. The control groups
received the same volume of vehicle [7]. All animals were sacri-
ﬁced at one day after the ﬁnal injection (with fasting), and received
care according to the guidelines published by National Institutes of
Health and approved by the local ethics committee of Fudan
University.
2.2. Biochemical assays
All serum samples from individual mice were obtained and
stored at 80 C until use. Serum alanine aminotransferase (ALT),
aspartate aminotransferase (AST), alkaline phosphatase (ALP) and
total bilirubin (TBIL) levels were determined using the commercial
kits (Nanjing Jiancheng Biotechnology Institute, China).
2.3. Histological analyses
For morphometric analyses, the liver tissues maintained in 10%
buffered formalin and embedded in parafﬁn were sliced into
4 lm-thick sections. Then, the sections were stained with
hematoxylin and eosin (H&E) to monitor histological changes. To
evaluate collagen deposition, Masson’s trichrome staining and
Sirius red staining were performed. For detection of hepatic stellate
cell activation and inﬂammatory inﬁltration, all slides were stained
with monoclonal antibodies smooth muscle alpha-actin (a-SMA,
Sigma) and F4/80 (AbD Serotech, Raleigh, NC). Histological analy-
ses were performed according to standard procedures described
previously [18]. Besides, the extent of ﬁbrosis was quantiﬁed by
measuring percentages of Sirius red-positive pixels and counting
the number of a-SMA positive HSCs in the sinusoidal lining areain ﬁve randomly selected 200- or 400-fold magniﬁcation ﬁelds
per liver section [18].
2.4. Real-time PCR analysis
Total RNA from livers was prepared with Trizol reagent (Invitro-
gen) in accordance with the manufacturer’s protocol. Subse-
quently, reverse transcription and quantitative real-time PCR
were implemented using commercial kits (TaKaRa) according the
manufacturer’s instruction. And an ABI StepOne plus Sequence
Detection system was used to detect a series of changes of mRNA
levels associated with liver ﬁbrosis. Meanwhile, all ﬁnal results
were normalized relative to a housekeeping gene, GAPDH. The
primers were shown in Table 1.
2.5. Western blotting and nuclear factor kappa B (NF-jB) activity
measurements
Western blotting was carried out as described [19]. Primary
antibodies used included those against a-SMA (Sigma), GAPDH
(Santa Cruz Biotechnology), pThr202/pTyr204-ERK1/2, ERK1/2,
pThr183/pTyr185-JNK, JNK, pThr180/pTyr182-p38, p38 (Cell Sig-
naling Technology). Nuclear extracts were prepared according to
the Nuclear Extract Kit (Active Motif). NF-jB activation was
assessed in nuclear extracts by means of the NF-jB Transcription
Factor Assay Kit (TransAM™) from Active Motif as described [20].
2.6. Statistical analysis
All results were expressed as mean ± SEM. Comparisons
between different groups were assessed by the Student t test and
one-way ANOVA analysis using GraphPad Prism 5 (GraphPad Soft-
ware). P < 0.05 was considered signiﬁcant.
Additional materials and methods are shown in Supplemental
information.
3. Results
3.1. TLR2 deﬁciency reduces liver injury and collagen accumulation
upon CCl4 administration
We determined the serum levels of liver enzymes including
ALT, AST, ALP, and TBIL. As shown in Fig. 1A, 6 weeks injection of
CCl4 led to a marked elevation in ALT, AST, ALP, and TBIL levels.
TLR2 deﬁciency had no effect on CCl4-induced elevation in serum
ALT and AST levels. However, TLR2 deﬁciency suppressed the
CCl4-induced increases in serum ALP and TBIL levels. In addition,
histological analysis revealed that hepatocellular necrosis and
inﬁltration of inﬂammatory cells aroused by prolonged CCl4
Fig. 1. CCl4-induced liver injury and collagen accumulation are diminished in TLR2/ mice. (A) Liver injury was measured by Serum ALT, AST, ALP and TBIL. (B) Hematoxylin
and eosin (H&E) staining of liver sections fromWT and TLR2/ mice treated with vehicle or CCl4 (original magniﬁcation, 100). (C and D) Representative images of Masson’s
trichrome and Sirius red staining of livers from WT and TLR2/ mice treated with vehicle or CCl4 (original magniﬁcation, 100). (E and F) Histomorphometric analysis of
stained sections, expressed as percentage of positive pixels. (G) Liver Col1A1 messenger RNA levels were determined by quantitative polymerase chain reaction. Values
represent means ± SEM for 9 vehicle and 10 CCl4 treated mice. ⁄P < 0.05, ⁄⁄P < 0.001.
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Masson’s trichrome and Sirius red staining for ﬁbrosis (Fig. 1C–F)
also demonstrated a marked decrease in CCl4-induced ECM
collagen deposition in TLR2/ mice compared with WT mice. This
was further conﬁrmed by the expression of type I procollagen a1
chain (Col1A1) mRNA (Fig. 1G), which encodes the pro-alpha1
chains of type I collagen. Taken together, these results suggested
that TLR2 could mediate CCl4-induced liver injury and collagen
accumulation.
3.2. TLR2 deﬁciency inhibits hepatic stellate cell activation upon CCl4
administration
In view of the fact that activated HSC was considered as the
main source of collagen in liver tissue, we then performed liver
immunohistochemistry for the activated stellate cell marker
a-SMA (Fig. 2A). Compared with WT littermates administrated of
CCl4, less a-SMA-positive cells were observed in the periductularregions of TLR2/ ﬁbrotic animals. This is in agreement with those
obtained by semiquantitative assays of a-SMA mRNA levels
(Fig. 2B) and Western blot analysis of a-SMA protein expression
(Fig. 2C). Simultaneously, HSCs isolated from TLR2/ mice also
exhibited reduced pro-inﬂammatory response after TGF-b1
stimulation in vitro (Supplementary Fig. 1A–D). Collectively, these
ﬁndings indicated that TLR2 could decrease liver collagen deposi-
tion through inhibiting the activation of HSCs.
3.3. TLR2 deﬁciency decreases inﬂammatory inﬁltration and reduces
mRNA level of proﬁbrotic and proinﬂammatory cytokines in liver upon
CCl4 administration
Inﬂammatory mediators from Kupffer cells have been proved to
play a pivotal role in HSCs activation and ﬁbrogenesis [21]. To
explore whether TLR2 regulate inﬂammatory inﬁltration during
ﬁbrosis, we performed F4/80 immunohistochemistry staining to
determine macrophages inﬁltration. Our result showed that TLR2
Fig. 2. CCl4-induced hepatic stellate cell activation is ameliorated in TLR2/ mice.
(A) Immunohistochemical staining of a-SMA in the livers of WT and TLR2/ mice
treated with vehicle or CCl4 (original magniﬁcation, 100). (B) Real-time quanti-
tative PCR analysis of a-SMA mRNA expression in groups. (C) Expression of a-SMA
was determined by Western blot analysis. Values represent means ± SEM for 9
vehicle and 10 CCl4 treated mice. ⁄P < 0.05.
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Immunohistochemistry staining of neutrophils (Gr-1), CD4 T
lymphocytes and CD19 B lymphocytes also demonstrated the
anticipated alterations (Supplementary Fig. 2).Fig. 3. TLR2 deﬁciency protects against CCl4-induced hepatic inﬂammation and ﬁbroge
immunohistochemistry (original magniﬁcation, 100). (B) Real-time quantitative PCR an
and Ccl4. (C) Real-time quantitative PCR analysis of hepatic expression of proﬁbrotic gen
and 10 CCl4 treated mice. ⁄P < 0.05.In response to liver damage caused by CCl4, proinﬂammatory
factors such as TNF-a, IL-6, MCP-1 Ccl4, CXCL-1 and CXCL-2 were
upregulated in liver. Quantitative R‘T-PCR analysis and ELISA
analysis revealed a strong suppression of pro-inﬂammatory
response in TLR2/ mice as compared with WT mice after
treatment of CCl4 (Fig. 3B and Supplementary Fig. 3). Similarly,
the hepatic expression of proﬁbrotic molecules, including TGF-b,
TIMP1 and PDGFR, were also down-regulated in CCl4-treated
TLR2/ mice (Fig. 3C). Meanwhile, we further tested the expres-
sion of TLR4 and found that the mRNA and proteins levels of
TLR4 were decreased in TLR2/ mice compared to WT mice after
CCl4 treatment (Supplementary Fig. 4).
3.4. TLR2 deﬁciency attenuates mitogen-activated protein kinases
(MAPK) phosphorylation and NF-jB activation in liver upon CCl4
administration
To identify potential molecular mechanisms of TLR2-mediated
pro-ﬁbrogenic effect during CCl4-induced liver ﬁbrosis, several
well-documented signaling pathways connected with liver ﬁbrosis
were investigated in liver [22,23]. Though equal amounts of ERK1/
2 protein were detected, CCl4-induced ERK1/2 phosphorylation
was signiﬁcantly diminished in TLR2/ mice compared with WT
mice (Fig. 4A). Likewise, CCl4-induced phosphorylation of p38
and JNK were also signiﬁcantly decreased in TLR2/ mice
compared with WT mice, afﬁrming attenuated proinﬂammatory
signaling (Fig. 4B and C). Moreover, we observed impaired NF-jB
activation in CCl4-treated TLR2/ mice compared with CCl4-
treated WT mice. The similar pattern was observed in in vitro
activated HSCs and macrophages isolated from wild-type and
TLR2/ mice (Supplementary Fig. 5). Altogether, these resultsnesis. (A) Macrophages inﬁltration after injection of CCl4 were evaluated by F4/80
alysis of hepatic expression of pro-inﬂammatory genes including TNF-a, IL-6, MCP-1
es including TGF-b, TIMP1 and PDGFR. Values represent means ± SEM for 9 vehicle
Fig. 4. CCl4-induced MAPK and NF-jB activation is attenuated in TLR2/ mice.
Phosphorylation of (A) ERK1/2, (B) P38 and (C) JNK was determined byWestern blot
analysis in lysed liver tissue. (D) NF-jB activation was assessed in nuclear extracts.
Values represent means ± SEM for 9 vehicle and 10 CCl4 treated mice. ⁄P < 0.05.
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MAPK and NF-jB signaling pathways.
4. Discussion
Liver ﬁbrosis occurs in virtually many types of chronic liver
diseases and is characterized by a reversible accumulation of col-
lagenous matrix and sustained inﬂammation [10,24,25]. In view
of its crucial role in regulation of inﬂammation even under injury
and wound healing, TLR2 has been implicated in a number of
chronic liver diseases [10]. To date, a series of studies about the
relationship between TLR2 and liver ﬁbrosis have been published,
but no clear consensus has been reached [7,17]. Especially, the
in-depth molecular link between TLR2 signaling and chronic liver
ﬁbrosis remains elusive. In previous studies, Hartmann et al. [26]
employed bile duct ligation (BDL) mice to demonstrated that
TLR2 signaling on monocytes in the lamina propria is important
in intestinal inﬂammation and bacterial translocation that contrib-
uted to liver ﬁbrosis. In addition, Moles et al. [27], using an acute
liver injury mouse model, showed that TLR2 is required for optimal
recruitment of neutrophils to the hepatic parenchyma, but is dis-
pensable for subsequent wound-repair/ﬁbrogenesis and regenera-
tive responses. However, Seki et al. [7] observed that TLR4, but not
TLR2, are required for BDL-induced hepatic ﬁbrosis. Hence, in the
current study, we analyzed liver ﬁbrosis marker and ﬁbrosis-
related molecular alterations in a model of CCl4-induced ﬁbrosis.
Using this model, we found that TLR2 deﬁciency protected against
the HSCs activation and liver ﬁbrosis mainly through inhibiting
MAPK and NF-jB signaling pathways.
Administration of CCl4 in mice duplicates the liver damage,
activation of HSCs and liver ﬁbrosis observed in chronic human
liver disease. Our data indicated that accumulation of collagen in
CCl4-treated TLR2/ mice was signiﬁcantly reduced as compared
with that in WT mice (Fig. 1C and D), as well as the a-SMA produc-
tion (Fig. 2). Interestingly, following injection of CCl4, liver injury as
measured by ALT and AST levels was not signiﬁcantly different in
wild-type and TLR2/ mice (Fig. 1A), indicating that TLR2 does
not mediate CCl4 hepatotoxicity but ﬁbrosis progression. Mean-
while, ALP and TBIL levels were reduced in TLR2/ mice relative
to WT mice following CCl4 treatment (Fig. 1A), suggesting that
TLR2 may contribute to CCl4-induced bile duct injury. Though the
expression level of TLR2 in hepatocytes is very low and its
responses are fairly weak in vivo, non-parenchymal liver cells, such
as the Kupffer cells, HSCs and biliary epithelial cells, express
relatively abundant level of TLR2 [28]. It is evident that non-
parenchymal liver cells are primarily responsible for the produc-
tion of ECM components. And they are also considered to be the
main source of proﬁbrotic molecules and proinﬂammatory factors[15]. In agreement with previous studies that TLR2 activation
induced proﬁbrotic molecules and proinﬂammatory cytokines pro-
duction in non-parenchymal liver cells in vitro [29,30], We found
that the protection effect of TLR2 deﬁciency on CCl4-induced liver
ﬁbrosis was accompanied by downregulating of proinﬂammatory
and proﬁbrotic mediators including TNF-a, IL-6, MCP-1, Ccl4,
CXCL-1, CXCL-2, PDGFR, TGF-b and TIMP1 in vivo (Fig. 3B and C
and Supplementary Fig. 2). Moreover, TLR2 deﬁciency was associ-
ated with less hepatic inﬂammation, as determined by reduced
macrophages and neutrophils inﬁltration in CCl4-induced liver
ﬁbrosis (Fig 3A and Supplementary Fig. 2).
The MAPK family includes extracellular signal-regulated kinase
(ERK), c-Jun N-terminal kinase (JNK), and p38 MAPK. Once these
molecules are activated, they recruit to Ras, which leads to the
transcription of cell-proliferative and proﬁbrogenic factors. MAPKs
have been reported to be critical for HSCs activation and collagen
synthesis. Suppression of ERK activation was associated with com-
plete inhibition of HSCs proliferation in vitro [31]. JNK inhibition
prevented TGF-b induced murine HSCs activation and decreased
TGF-b signaling in human HSCs in vitro [32]. JNK inhibition also
signiﬁcantly reduced CCl4-induced liver ﬁbrosis in vivo [32]. In
addition to MAPKs, NF-jB, a master regulator of inﬂammation
and cell death, also plays a key role in regulating the survival of
hepatocytes, inﬂammation in Kupffer cells, and survival, inﬂamma-
tion and activation in HSCs [33]. The crucial role of NF-jB in the
liver is underlined by the fact that NF-jB inhibitors block hepatic
ﬁbrogenesis in experimental models of liver ﬁbrosis [34]. In the
present study, we found that TLR2 deﬁciency attenuated activities
of MAPK and NF-jB in in vitro activated HSCs and macrophages
(Supplementary Fig. 5). MAPK and NF-jB signaling were activated
after CCl4 treatment in vivo, which is in line with previous reports.
Interestingly, TLR2 deﬁciency signiﬁcantly inhibited CCl4-induced
activation of MAPK and NF-jB (Fig. 4), suggesting that TLR2 is crit-
ical for the activation of MAPK and NF-jB in the mouse model of
CCl4-induced hepatotoxicity.
In summary, our studies show that HSCs activation and inﬂam-
mation response during CCl4-induced liver ﬁbrosis are associated
with TLR2 mediated MAPK and NF-jB signaling pathways. These
results introduce a new aspect of TLR2 biology potentially related
to the pathogenesis of liver ﬁbrosis. Thus, TLR2 inhibition appears
to be a promising strategy for the prevention of hepatic ﬁbrosis in
patients with chronic liver disease.
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